BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 920242)

  • 1. Studies on replacement and suppressive dosages of 1-thyroxine.
    Nilsson G; Pettersson U; Levin K; Hughes R
    Acta Med Scand; 1977; 202(4):257-60. PubMed ID: 920242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the optimal thyroxine dose with the TRH test for replacement and suppression therapy].
    Erne P; Staub JJ; Althaus B; Fleig Y; Girard J
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1922-3. PubMed ID: 6420884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seasonal variation of serum thyrotropin concentration and thyrotropin response to thyrotropin-releasing hormone in patients with primary hypothyroidism on constant replacement dosage of thyroxine.
    Konno N; Morikawa K
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1118-24. PubMed ID: 6804476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of serum total thyroxine, triiodothyronine, free thyroxine, and thyrotropin concentrations for diagnosis of hypothyroidism in dogs.
    Peterson ME; Melián C; Nichols R
    J Am Vet Med Assoc; 1997 Dec; 211(11):1396-402. PubMed ID: 9394888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum T4, T3, and TSH levels in primary hypothyroidism during replacement therapy with thyroxine.
    Brajkovich IE; Mashiter K; Joplin GF; Cassar J
    Metabolism; 1983 Aug; 32(8):745-7. PubMed ID: 6865774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free thyroxine, free triiodothyronine, and thyrotropin concentrations in hypothyroid and thyroid carcinoma patients receiving thyroxine therapy.
    Liewendahl K; Helenius T; Lamberg BA; Mähönen H; Wägar G
    Acta Endocrinol (Copenh); 1987 Nov; 116(3):418-24. PubMed ID: 3687325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal thyroxine and elevated thyrotropin concentrations: evolving hypothyroidism or persistent euthyroidism with reset thyrostat.
    Kabadi UM; Cech R
    J Endocrinol Invest; 1997 Jun; 20(6):319-26. PubMed ID: 9294777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoradiometric assay for basal thyroid-stimulating hormone levels: strategy for the management of thyroxine replacement.
    Garces J; Barsano CP
    South Med J; 1988 Sep; 81(9):1127-31. PubMed ID: 3420444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appropriate replacement dose of thyroxine in primary hypothyroidism.
    Frey H; Johannesen O; Kapelrud H; Sand T
    Acta Med Scand; 1987; 222(2):163-7. PubMed ID: 3673668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroxine replacement therapy and circulating lipid concentrations.
    Franklyn JA; Daykin J; Betteridge J; Hughes EA; Holder R; Jones SR; Sheppard MC
    Clin Endocrinol (Oxf); 1993 May; 38(5):453-9. PubMed ID: 8330440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in serum levels of T3, T4, FT4 and TSH during thyroxine replacement therapy.
    Wennlund A
    Acta Endocrinol (Copenh); 1986 Sep; 113(1):47-9. PubMed ID: 3766048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [TRH refractory TSH values, triiodothyronine levels and T3/T4 quotients in hypothyroid children treated with T3/T4 preparations (author's transl)].
    Hesse V; Lauterbach H; Stoll W
    Klin Wochenschr; 1977 Feb; 55(3):131-5. PubMed ID: 401919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of replacement and suppressive doses of thyroxine.
    Banovac K; Carrington SA; Levis S; Fill MD; Bilsker MS
    J Int Med Res; 1990; 18(3):210-8. PubMed ID: 2361563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of prednisone on serum thyrotropin, thyroxine and triiodothyronine concentrations in hypothyroid patients.
    Jensen J; Nolan G; Jubiz W
    J Endocrinol Invest; 1978 Apr; 1(2):171-3. PubMed ID: 114570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in serum triiodothyronine, thyroxine, and thyrotropin during treatment with thyroxine in severe primary hypothyroidism.
    Maeda M; Kuzuya N; Masuyama Y; Imai Y; Ikeda H
    J Clin Endocrinol Metab; 1976 Jul; 43(1):10-7. PubMed ID: 947930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased sensitivity of thyrotropin-thyroid hormone feedback control in hypothyroid and athyreotic patients treated with levothyroxine. Is serum triiodothyronine involved?
    Solter D; Solter M
    Ann Endocrinol (Paris); 2018 Apr; 79(2):62-66. PubMed ID: 29530271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of serum T4 and T3 to TSH in primary hypothyroidism.
    Ryder S; Gollapudi GM; Varma A
    Arch Intern Med; 1980 Oct; 140(10):1290-1. PubMed ID: 6775609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns off recovery of the hypothalamic-pituitary-thyroid axis in patients taken of chronic thyroid therapy.
    Krugman LG; Hershman JM; Chopra IJ; Levine GA; Pekary E; Geffner DL; Chua Teco GN
    J Clin Endocrinol Metab; 1975 Jul; 41(1):70-80. PubMed ID: 807596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the nocturnal serum thyrotropin (TSH) surge, as assessed by TSH ultrasensitive assay, in patients receiving long term L-thyroxine suppression therapy and in patients with various thyroid disorders.
    Bartalena L; Martino E; Falcone M; Buratti L; Grasso L; Mammoli C; Pacchiarotti A; Aghini-Lombardi F; Balzano S; Pinchera A
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1265-71. PubMed ID: 3680483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-term treatment with thyroxine on pituitary TSH secretion and heart action in patients with hypothyroidism.
    Yamauchi K; Takasu N; Ichikawa K; Yamada T; Aizawa T
    Acta Endocrinol (Copenh); 1984 Oct; 107(2):218-24. PubMed ID: 6495989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.